FDA 483 - Baxter Healthcare Corporation - July 19, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Baxter Healthcare Corporation, a sterile drug manufacturer in Jayuya, PR, revealed significant deficiencies in quality control and manufacturing processes. The firm failed to adequately investigate Out of Specification results and laboratory errors, maintain contemporaneous documentation, and ensure proper equipment cleaning and maintenance. These issues collectively compromise product quality, data integrity, and the sterility assurance of drug products.
ID · 354827b8-1c77-492e-af58-0025cbb0d027